SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-04-001307
Filing Date
2004-03-15
Accepted
2004-03-15 16:31:46
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. FORM 10-K b49051aie10vk.htm 10-K 912668
3 EX-10.4 SCHEDULE TO INDEMNIFICATION AGREEMENT b49051aiexv10w4.txt EX-10.4 632
4 EX-10.27 AMENDMENT NO. 2 TO RESEARCH AGREEMENT b49051aiexv10w27.txt EX-10.27 12877
5 EX-21 SUBSIDIARIES OF ANTIGENICS b49051aiexv21.txt EX-21 341
6 EX-23 CONSENT OF KPMG LLP b49051aiexv23.txt EX-23 1455
7 EX-31.1 SECTION 302 CEO CERTIFICATION b49051aiexv31w1.txt EX-31.1 3618
8 EX 31.2 SECTION 302 CFO CERTIFICATION b49051aiexv31w2.txt EX-31.2 3573
9 EX-32.1 SECTION 906 CEO & CFO CERTIFICATIONS b49051aiexv32w1.txt EX-32.1 1807
  Complete submission text file 0000950135-04-001307.txt   939500
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29089 | Film No.: 04669930
SIC: 2836 Biological Products, (No Diagnostic Substances)